CRI Genetics AI Market Strategy Report - DNA Testing Kits

Answer Capsule

CRI Genetics holds negligible AI recommendation power in the DNA testing kit category, appearing in just 2.1% of AI responses and earning valid recommendation credit in only 0.7% of observations. The brand records zero rank-one placements and a top-three rate below 1%, placing it at the bottom of AI-generated shortlists across the benchmark. Its net sentiment score of 0.46 is the lowest among all ten tracked brands, indicating mixed framing on the rare occasions the brand does appear. The clearest opportunity is building a foundational public evidence layer that converts rare mentions into positive, shortlist-quality recommendations.

Who This Report Is For

This report is for CRI Genetics marketing, brand, and growth leadership responsible for understanding how AI-driven discovery is shaping buyer consideration in the DNA testing kit category.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: CRI Genetics
• Category / market studied: DNA Testing Kits
• Reporting month: August 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 1 (Best DNA Testing Kits, Discovery and Evaluation)
• AI observations analyzed: 607
• Competitors tracked: 10

Executive Summary

CRI Genetics is effectively absent from AI-driven discovery in the DNA testing kit category. The brand appears in just 13 of 607 observations, a raw mention presence rate of 2.1%. Of those 13 mentions, only 4 earn valid recommendation credit, representing 0.7% of all observations. The brand records zero rank-one placements and just one top-three placement across the entire benchmark period.

The sentiment picture compounds the visibility problem. CRI Genetics posts a net sentiment score of 0.46, the lowest among all ten tracked brands. The brand receives 6 positive mentions and 7 neutral mentions, with no negative mentions recorded. When AI systems do reference CRI Genetics, the framing is nearly as likely to be neutral as positive, which limits the brand's ability to convert even its rare appearances into recommendation power.

The strongest platform signal in the dataset is Google AI Mode, where CRI Genetics appears in 11 of 169 observations. This is the only platform where the brand achieves any meaningful presence, though valid recommendation coverage on that platform remains below 2%. The competitive gap is sharpest on ChatGPT, Gemini, and Perplexity, where the brand records zero mentions across the full benchmark.

Within the one public cluster available for analysis, covering discovery and evaluation prompts, CRI Genetics holds an average recommended rank of 4.25. That figure places the brand at the lower end of AI-generated shortlists on the occasions it earns rank credit at all. The evidence suggests CRI Genetics has a source presence problem: the brand is rarely retrieved, rarely framed as a recommendation, and almost never advanced as a first or top-three choice when buyers are actively comparing DNA testing options.

What CRI Genetics Is Winning

CRI Genetics has very few evidence-backed wins in this benchmark, and the available wins are narrow in scope.

The brand records zero negative mentions across all 607 observations. While the sample is small, the absence of negative framing means there is no active reputational drag in the AI responses that do mention the brand. CRI Genetics is not being criticized or cautioned against; it is simply not being surfaced.

When the brand does appear, roughly half of those mentions are positive. The positive visibility rate of 0.99% is a weak signal given the tiny sample, but it suggests the brand is not being undermined by adverse framing when it does reach AI responses.

The most structurally meaningful win is that CRI Genetics does appear in Google AI Mode, which is the highest-volume platform in the benchmark at 169 observations. This presence, however limited, gives the brand an existing foothold in the platform where buyers are most actively comparing DNA testing options in this dataset.

Where CRI Genetics Has the Clearest AI Visibility Gaps

The clearest gap is total platform absence. CRI Genetics records zero mentions in ChatGPT, Gemini, and Perplexity. These platforms represent a substantial portion of AI-driven discovery, and the brand is simply not part of the conversation on any of them.

The second gap is recommendation conversion. Even where the brand appears, it is rarely advanced as a choice. CRI Genetics earns valid recommendation credit in only 0.7% of all observations, with a top-ten rate of 0.66%. The brand is mentioned but not shortlisted, a pattern that leaves it commercially invisible at the decision moment.

The third gap is framing quality. CRI Genetics posts the lowest net sentiment score in the category at 0.46. For comparison, AncestryDNA posts 0.78, FamilyTreeDNA posts 0.81, and Nebula Genomics posts 0.87. When AI systems reference CRI Genetics, the framing is mixed, which reduces the probability of recommendation credit even when the brand is retrieved.

The competitive displacement picture is stark. AncestryDNA appears in 99.7% of responses and holds the top recommendation slot in 66.4% of cases. 23andMe appears in 96.2% of responses with a 59.8% top-three rate. Even Living DNA, which the benchmark characterizes as visible but under-recommended, appears in 23.9% of responses. CRI Genetics is not competing for shortlist position; it is competing for basic retrieval.

Biggest Opportunity

The biggest opportunity for CRI Genetics is building a foundational public evidence layer that supports positive, retrievable, and recommendation-ready source material.

The brand's core problem is not rank position or top-three placement. It is that AI systems rarely retrieve CRI Genetics at all, and when they do, the framing is mixed. The path forward is establishing consistent official content, positive third-party coverage, and clear entity information that AI systems can retrieve and synthesize into favorable recommendations. This means prioritizing comparison content that positions the brand favorably, review coverage that provides third-party validation, and owned content that explains the brand's offering and credibility clearly. Without this foundation in place, CRI Genetics will continue to be mentioned rarely and recommended almost never, regardless of how much the brand invests in other channels.

Prompt Evidence

Google AI Mode / Discovery and Evaluation Prompt: "What is the best DNA ancestry kit to buy?" Result: CRI Genetics appears in a small share of responses but is rarely advanced as a recommended choice, consistent with its low valid recommendation coverage on this platform.

Google AI Overviews / Discovery and Evaluation Prompt: "What DNA test is more accurate?" Result: CRI Genetics earns a single valid recommendation with an average rank of 4, indicating low shortlist placement on the rare occasions the brand is surfaced.

Copilot / Discovery and Evaluation Prompt: "How do I check my ethnicity?" Result: CRI Genetics appears once as a neutral mention with no recommendation credit, showing presence without shortlist power.

ChatGPT / Discovery and Evaluation Prompt: "Which is the best DNA kit for ancestry?" Result: CRI Genetics records zero mentions, confirming full absence from a major AI discovery platform during the benchmark period.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map where CRI Genetics appears and disappears across all six platforms, identifying the specific prompts, source types, and competitor placements that define the brand's current visibility floor.

Phase 2: Recommendation Readiness Plan Build a targeted plan to convert rare mentions into valid recommendation credit by improving framing quality, shortlist eligibility, and entity clarity across the sources AI systems are most likely to retrieve.

Phase 3: Owned Answer Layer Buildout Develop official content that clearly explains CRI Genetics' product offering, testing methodology, and differentiation in language AI systems can retrieve, synthesize, and advance as a recommendation.

Phase 4: Citation and Authority Layer Development Strengthen third-party coverage, comparison content, and review sources that provide positive third-party validation and improve the brand's public evidence layer across the platforms where it currently has no presence.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track changes in mention presence, valid recommendation coverage, sentiment score, and average rank across platforms to measure progress against the August 2026 benchmark baseline.

Why This Matters

AI systems are becoming the shortlist builders for DNA testing kit purchases. When a buyer asks which DNA test is most accurate or which kit best fits their needs, the AI response effectively pre-selects the options they will consider. CRI Genetics is currently excluded from that pre-selection process, appearing in just 2.1% of responses and earning recommendation credit in less than 1% of observations.

Presence alone is not the goal. The benchmark shows that brands with meaningful mention rates can still fail to convert visibility into shortlist placement. For CRI Genetics, the challenge is more fundamental: the brand must first establish a retrievable, positively framed public evidence layer before it can compete for recommendation credit. The next move is targeted correction of the prompt, page, and citation layers that determine whether AI systems retrieve, trust, and advance the brand at the moment buyers are forming their decisions.

Core Metrics

• Mentions: 13
• Valid recommendations: 4
• Top 3 recommendation count: 1
• Rank 1 recommendation count: 0
• Average recommended rank: 4.25
• Positive mentions: 6
• Neutral mentions: 7
• Negative mentions: 0
• Raw mention presence rate: 2.1%
• Valid recommendation coverage: 0.7%
• Top 3 recommendation rate: 0.2%
• Rank 1 recommendation rate: 0.0%
• Strongest cluster by recommendation behavior: Best DNA Testing Kits, Discovery and Evaluation
• Strongest platform by recommendation behavior: Google AI Mode

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For CRI Genetics: (6 × 1 + 7 × 0 + 0 × -1) / 13 = 0.46

This score matters because unclassified mention counts are misleading. CRI Genetics appears in 13 responses, but only 6 of those are positive. The remaining 7 are neutral references that do not advance the brand as a choice. Treating all 13 as evidence of AI visibility overstates the brand's commercial position by a wide margin.

Share of voice is a diagnostic metric, not a business KPI. A 2.1% mention rate might suggest the brand has a foothold in AI discovery, but the 0.7% recommendation conversion rate shows that this presence carries almost no commercial weight in the current benchmark.

A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal outcomes. For CRI Genetics, the 7 neutral mentions represent lost opportunities where the brand is referenced but not advanced. Counting them as wins produces a false picture of recommendation health. Classified sentiment is required before any interpretation of AI visibility can be trusted as a strategic input.

Sentiment by Platform

Methodology

1. Report orientation: This is a benchmark-based AI market strategy report analyzing how AI platforms recommend DNA testing kit brands during the August 2026 reporting period. It is not a client implementation case study and does not reflect CiteWorks Studio client work or campaign outcomes.
2. Reporting window: Data was collected in August 2026, with extraction dated August 1, 2026.
3. Platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.
4. Observation count: 607 eligible observations were analyzed from 800 total prompts evaluated. 193 prompts were reserved and 448 unique questions were identified across the benchmark.
5. Competitor universe: AncestryDNA, 23andMe, African Ancestry, CRI Genetics, FamilyTreeDNA, Health Nucleus, Living DNA, MyHeritage DNA, Nebula Genomics, and tellmeGen.
6. Public clusters used: The public benchmark covers one high-intent cluster focused on discovery and evaluation prompts for identifying the best DNA testing kits. The full LLM Authority Index report includes 10 clusters spanning comparison, pricing, trust, and decision-stage prompts.
7. Stage 0 role: Raw AI observations were extracted and classified to determine mention presence, sentiment framing, and recommendation rank for each brand across all platforms before any metric aggregation.
8. Definition of a mention: A mention means the company appeared in an AI-generated response, regardless of whether it was recommended, listed neutrally, or framed negatively. Mention presence is not recommendation credit.
9. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality placement that earns recommendation credit. Neutral references, cautionary mentions, and comparison anchors are not counted as valid recommendations.
10. Ranking and scoring metrics used: Valid recommendation coverage, top-three rate, rank-one rate, top-ten rate, average recommended rank, raw mention presence rate, positive visibility rate, neutral visibility rate, negative visibility rate, and net sentiment score. Monetary or modeled value metrics from the source data are omitted from this public report.
11. Limitations: This is a point-in-time benchmark based on August 2026 data. AI platform outputs can change based on platform updates, index changes, and source availability. The public version of the benchmark includes one cluster; the full LLM Authority Index report includes 10 clusters. This report is not a comprehensive audit, a full market census, or a client engagement deliverable.

See How AI Is Recommending Your Brand

CiteWorks Studio maps where your brand appears in AI recommendations, which competitors are being advanced instead, which prompts carry the most commercial risk, and which sources are shaping AI answers in your category. An AI Visibility Audit or AI Market Discovery Profile can show you what needs to change to improve recommendation-stage visibility before the next benchmark cycle.